- Home
- TSHA vs CBAN Comparison
TSHA vs CBAN Comparison
Compare TSHA & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- CBAN
- Stock Information
- Founded
- TSHA 2019
- CBAN 1975
- Country
- TSHA United States
- CBAN United States
- Employees
- TSHA N/A
- CBAN N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- CBAN Major Banks
- Sector
- TSHA Health Care
- CBAN Finance
- Exchange
- TSHA Nasdaq
- CBAN Nasdaq
- Market Cap
- TSHA 313.6M
- CBAN 285.3M
- IPO Year
- TSHA 2020
- CBAN 1998
- Fundamental
- Price
- TSHA $1.53
- CBAN $15.78
- Analyst Decision
- TSHA Strong Buy
- CBAN
- Analyst Count
- TSHA 8
- CBAN 0
- Target Price
- TSHA $6.63
- CBAN N/A
- AVG Volume (30 Days)
- TSHA 2.3M
- CBAN 45.4K
- Earning Date
- TSHA 11-13-2024
- CBAN 01-22-2025
- Dividend Yield
- TSHA N/A
- CBAN 2.85%
- EPS Growth
- TSHA N/A
- CBAN 1.70
- EPS
- TSHA N/A
- CBAN 1.25
- Revenue
- TSHA $9,915,000.00
- CBAN $108,949,000.00
- Revenue This Year
- TSHA N/A
- CBAN N/A
- Revenue Next Year
- TSHA N/A
- CBAN $6.05
- P/E Ratio
- TSHA N/A
- CBAN $12.63
- Revenue Growth
- TSHA N/A
- CBAN N/A
- 52 Week Low
- TSHA $1.19
- CBAN $10.33
- 52 Week High
- TSHA $4.32
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- TSHA 34.16
- CBAN 46.10
- Support Level
- TSHA $1.56
- CBAN $16.09
- Resistance Level
- TSHA $1.75
- CBAN $15.78
- Average True Range (ATR)
- TSHA 0.16
- CBAN 0.41
- MACD
- TSHA -0.02
- CBAN 0.02
- Stochastic Oscillator
- TSHA 3.57
- CBAN 58.79
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.